The best thing you can do is talk to a medical team like NJBC who can look at your health history, your goals, and your response to medication to find the right fit
Li, J., et al
Genetic variations in these processes can pinpoint a subset of women and men with increased lifetime exposure to estrogens, estrogen metabolites, and other carcinogens
While the results are promising, a lot of evidence is anecdotal or from animal studies
Anderson, MD, MAS, an assistant professor of medicine from the University of Pittsburgh, clinical trials of several GLP-1 receptor agonists like semaglutide (Wegovy/Ozempic, Novo Nordisk) for weight loss included exclusion criteria of chronic medical and psychiatric conditions. However, [FDA] labeling does not restrict these treatments in these populations, they wrote in JAMA Internal Medicine
Eur J Clin Invest 22: 283-291, 1992